BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7994289)

  • 1. Synthesis, radiolabelling and stability of radioiodinated m-iodobenzylguanidine, a review.
    Wafelman AR; Konings MC; Hoefnagel CA; Maes RA; Beijnen JH
    Appl Radiat Isot; 1994 Oct; 45(10):997-107. PubMed ID: 7994289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of radioiodination of meta-iodobenzylguanidine (MIBG) catalysed by in situ generated Cu(I) and directly added Cu(II).
    Prabhakar G; Mehra KS; Ramamoorthy N; Chattopadhyay S; Oommen R; Narasimhan S; Nair NA; Gunasekaran S
    Appl Radiat Isot; 1999 Jun; 50(6):1011-4. PubMed ID: 10355103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fast high-yield labelling and quality control of [123I]- and [131I]MIBG.
    Verbruggen RF
    Int J Rad Appl Instrum A; 1987; 38(4):303-4. PubMed ID: 3040631
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid radiochemical purity testing for [131I]m-iodobenzylguanidine.
    Hung JC; Wilson ME
    Nucl Med Biol; 1995 Feb; 22(2):227-9. PubMed ID: 7767317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis and characterization of m-I-benzylguanidine].
    Bratouss A
    Radiobiol Radiother (Berl); 1988; 29(2):199-202. PubMed ID: 3399656
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of a kit-form analog of metaiodobenzylguanidine.
    Lee H; Inbasekaran MN; Wieland DM; Sherman PS; Fisher SJ; Mangner TJ; Rogers WL; Clinthorne NH
    J Nucl Med; 1986 Feb; 27(2):256-67. PubMed ID: 3712043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier-free 131I-meta-iodobenzylguanidine: comparison of production from meta-diazobenzylguanidine and from meta-trimethylsilylbenzylguanidine.
    Mairs RJ; Gaze MN; Watson DG; Skellern GG; Constable P; McKellar K; Owens J; Vaidyanathan G; Zalutsky MR
    Nucl Med Commun; 1994 Apr; 15(4):268-74. PubMed ID: 8072739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scintigraphy of a neuroblastoma with I-131 meta-iodobenzylguanidine.
    Kimmig B; Brandeis WE; Eisenhut M; Bubeck B; Hermann HJ; zum Winkel K
    J Nucl Med; 1984 Jul; 25(7):773-5. PubMed ID: 6737076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine production and quality control of 123I-labelled mIBG at NAC.
    Rossouw DD
    Int J Rad Appl Instrum A; 1992 Oct; 43(10):1301-2. PubMed ID: 1330981
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
    Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updating the procedure for metaiodobenzylguanidine labelling with iodine radioisotopes employed in industrial production.
    Franceschini R; Mosca R; Bonino C
    J Nucl Biol Med (1991); 1991; 35(4):183-5. PubMed ID: 1823814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry.
    Wafelman AR; Hoefnagel CA; Maes RA; Beijnen JH
    Eur J Nucl Med; 1994 Jun; 21(6):545-59. PubMed ID: 8082671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of carrier-free 131I-meta-iodobenzyl-guanidine by novel routes to enhance therapeutic efficiency in neuroblastoma.
    Gaze MN; Mairs RJ; Vaidyanathan G; Zalutsky MR
    Prog Clin Biol Res; 1994; 385():347-53. PubMed ID: 7972229
    [No Abstract]   [Full Text] [Related]  

  • 14. No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.
    Vaidyanathan G; Zalutsky MR
    Appl Radiat Isot; 1993 Mar; 44(3):621-8. PubMed ID: 8472027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A convenient solution-phase method for the preparation of meta-iodobenzylguanidine in high effective specific activity.
    Donovan AC; Valliant JF
    Nucl Med Biol; 2008 Oct; 35(7):741-6. PubMed ID: 18848658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine.
    Wieland DM; Wu J; Brown LE; Mangner TJ; Swanson DP; Beierwaltes WH
    J Nucl Med; 1980 Apr; 21(4):349-53. PubMed ID: 7381563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical concept and synthesis of a radioiodinated phenylfatty acid for in vivo metabolic studies of the myocardium.
    Machulla HJ; Marsmann M; Dutschka K
    Eur J Nucl Med; 1980 Apr; 5(2):171-3. PubMed ID: 7379820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(m-[125I]iodophenyl)maleimide: an agent for high yield radiolabeling of antibodies.
    Khawli LA; van den Abbeele AD; Kassis AI
    Int J Rad Appl Instrum B; 1992 Apr; 19(3):289-95. PubMed ID: 1629018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiochemical purity, at expiry, and radiochemical stability of iodine-131 labelled meta-iodobenzylguanidine concentrates for intravenous infusion.
    Wafelman AR; Hoefnagel CA; Maes RA; Beijnen JH
    Nuklearmedizin; 1996 Aug; 35(4):122-5. PubMed ID: 8784866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of m-iodobenzylguanidine in serum and urine by high-performance liquid chromatography.
    Schwabe D; Rohrbach E; Köhl U
    J Chromatogr; 1989 Jan; 487(1):177-82. PubMed ID: 2715263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.